In contrast, hepatocyte SIRT1 was dispensable for NAMPT to produce therapeutic effects on light-cycle thermogenesis, dyslipidemia, and hepatic de novo lipogenesis. The gene discussed is SIRT1; the disease is metabolic syndrome.